Finstal-5

Finstal-5

finasteride

Manufacturer:

Stallion Labs

Distributor:

Genace Pharma

Marketer:

Ambica
Concise Prescribing Info
Contents
Finasteride
Indications/Uses
Symptomatic BHP w/ an enlarged prostate to improve urinary flow & symptoms associated w/ BHP causing regression of the enlarge prostate. Decrease incidence of acute urinary retention; surgery including transurethral reaction of the prostate & prostatectomy.
Dosage/Direction for Use
BPH 5 mg daily for 6 mth. Alopecia androgenetica 1 mg daily for >3 mth.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity. Not indicated for use in women & childn. Women of childbearing potential. Pregnancy.
Special Precautions
Monitor patients w/ large residual urine vol &/or severely diminished urinary flow for obstructive neuropathy. Malignancies (prostate cancer) should be excluded before treatment. Require digital rectal exam & other evaluations for prostate cancer prior to therapy & periodically thereafter. Evaluate serum prostate-specific antigen conc during treatment. Male patients should wear condom or otherwise avoid exposure of women at risk of becoming pregnant; exposure of pregnant women may risk to male fetus. Lactation.
Adverse Reactions
Impotence, decreased libido, decreased vol of ejaculate, ejaculation disorders, gynecomastia, hypersensitivity reactions including pruritus, urticaria & swelling of the lips & face; testicular pain; skin rash.
ATC Classification
G04CB01 - finasteride ; Belongs to the class of testosterone-5-alpha reductase inhibitors. Used in the treatment of benign prostatic hypertrophy.
Presentation/Packing
Form
Finstal-5 FC tab 5 mg
Packing/Price
30's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in